Vaccination against HBV began 30 years ago with availability of plasma-derived, inactivated HBsAg vaccines. Soon after, recombinant HBsAg expressed in yeast cells led to the production of vaccines ...

a mathematical model based on epidemiological data was developed to estimate the global HBV disease burden and vaccination impact. [2] For the year 2000, the model estimated that 620,000 persons ...

NHS data showed a 40% increase in the detection of blood-borne infections, including HIV, during a 2023 pilot.

The alarming surge in liver cancer across Malaysia has sparked serious concern among health experts, with fatty liver disease ...

A national cancer control plan is a strategy document designed to set cancer control priorities. It focuses on prevention, ...

and its six etiologies (liver cancer due to hepatitis B, hepatitis C, alcohol use, other causes, NASH and hepatoblastoma) in China between 1990 and 2021 were extracted from the Global Burden of ...

In their effort to answer a decades-old biological question about how the hepatitis B virus (HBV) is able to establish ...

Researchers say if their results are confirmed through further study they are optimistic the approach could be used to treat chronic infections for the first time.

A new study analyzes the disease burden and the risk factors for severity among people who suffer from a condition called cannabinoid hyperemesis syndrome. Researchers say the condition occurs in ...

Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo g ...

Assessment of liver fibrosis and cirrhosis is crucial for the management of patients with chronic hepatitis B. The presence of at least moderate liver fibrosis is an important indication for antiviral ...